JP2012506439A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506439A5
JP2012506439A5 JP2011533266A JP2011533266A JP2012506439A5 JP 2012506439 A5 JP2012506439 A5 JP 2012506439A5 JP 2011533266 A JP2011533266 A JP 2011533266A JP 2011533266 A JP2011533266 A JP 2011533266A JP 2012506439 A5 JP2012506439 A5 JP 2012506439A5
Authority
JP
Japan
Prior art keywords
alkyl
fluoro
iodo
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011533266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506439A (ja
Filing date
Publication date
Priority claimed from GBGB0819280.9A external-priority patent/GB0819280D0/en
Application filed filed Critical
Publication of JP2012506439A publication Critical patent/JP2012506439A/ja
Publication of JP2012506439A5 publication Critical patent/JP2012506439A5/ja
Pending legal-status Critical Current

Links

JP2011533266A 2008-10-21 2009-10-20 イメージング及び放射線治療法 Pending JP2012506439A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10700108P 2008-10-21 2008-10-21
GB0819280.9 2008-10-21
US61/107,001 2008-10-21
GBGB0819280.9A GB0819280D0 (en) 2008-10-21 2008-10-21 Imgaing and radiotherapy methods
PCT/US2009/061271 WO2010048144A2 (en) 2008-10-21 2009-10-20 Imaging and radiotherapy methods

Publications (2)

Publication Number Publication Date
JP2012506439A JP2012506439A (ja) 2012-03-15
JP2012506439A5 true JP2012506439A5 (enExample) 2013-05-09

Family

ID=40097766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533266A Pending JP2012506439A (ja) 2008-10-21 2009-10-20 イメージング及び放射線治療法

Country Status (12)

Country Link
US (1) US20110286922A1 (enExample)
EP (1) EP2349351A2 (enExample)
JP (1) JP2012506439A (enExample)
KR (1) KR20110074988A (enExample)
CN (1) CN102186505A (enExample)
AU (1) AU2009307783A1 (enExample)
BR (1) BRPI0919690A2 (enExample)
CA (1) CA2738955A1 (enExample)
GB (1) GB0819280D0 (enExample)
MX (1) MX2011004161A (enExample)
RU (1) RU2011113996A (enExample)
WO (1) WO2010048144A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8540968B2 (en) 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
DE602005015687D1 (de) 2004-03-02 2009-09-10 Cellectar Inc Phospholipid-analoga für die behandlung von krebs
CU23844B1 (es) * 2009-04-17 2012-10-15 Ct De Neurociencias De Cuba Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer
SI3708192T1 (sl) * 2009-06-12 2023-12-29 Cellectar, Inc. Eter fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic
EP2515949A1 (en) * 2009-12-22 2012-10-31 GE Healthcare UK Limited Aldehydes for in vivo imaging of aldh in cancer stem cells
WO2012074840A2 (en) * 2010-11-22 2012-06-07 The General Hospital Corporation Compositions and methods for in vivo imaging
WO2013012754A1 (en) * 2011-07-15 2013-01-24 University Of Southern California Boron-based dual imaging probes, compositions and methods for rapid aqueous f-18 labeling, and imaging methods using same
WO2013048832A1 (en) * 2011-09-29 2013-04-04 Ge Healthcare Limited 18 f - labelled 6 - ( 2 - fluoroethoxy) - 2 - naphthaldehyde for detecting cancer stem cells
WO2013048811A1 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Imaging and radiotherapy methods for tumour stem cells
US8927732B2 (en) * 2012-03-30 2015-01-06 General Electric Company Biotin stannane for HPLC-free radioiodination
WO2014145493A1 (en) * 2013-03-15 2014-09-18 The Johns Hopkins University Radioactive substrates for aldehyde dehydrogenase
EP3450963A4 (en) * 2016-04-28 2020-01-29 National University Corporation Nagoya University FLUORESCENT PROBE, METHOD FOR DETECTING FLUORESCENCE AND METHOD OF USING FLUORESCENT PROBE
FR3054564B1 (fr) * 2016-07-28 2018-08-31 Advanced Biodesign Substrat specifique d'une isoenzyme de l'aldh
KR101941223B1 (ko) * 2017-04-04 2019-01-22 을지대학교 산학협력단 복강경 수술용 삼중 융합영상장치
JP2023025307A (ja) * 2020-01-31 2023-02-22 国立大学法人 東京大学 アルデヒドロゲナーゼ1a1検出用青色蛍光プローブ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876956A (en) * 1995-05-15 1999-03-02 Johns Hopkins University School Of Medicine Methods for identification or purification of cells containing an enzymatic intracellular marker
WO2003093498A1 (en) * 2002-04-29 2003-11-13 The Ohio State University Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0502277D0 (en) * 2005-02-04 2005-03-09 Amersham Plc Novel imaging agents
US20080058316A1 (en) * 2006-02-27 2008-03-06 The Johns Hopkins University Cancer treatment with gama-secretase inhibitors
WO2008036419A2 (en) * 2006-09-22 2008-03-27 The Regents Of The University Of Michigan Aldehyde dehydrogenase 1(aldh1) as a cancer stem cell marker

Similar Documents

Publication Publication Date Title
RU2011113996A (ru) Способы визуализации и радиотерапии
CN101668547B (zh) 选择缺氧组织的弱碱性2-硝基咪唑递送剂及其应用方法
EP2764406B1 (en) Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties
JP2010523599A5 (enExample)
RU2594167C2 (ru) Композиции пептидных радиоактивных индикаторов
CN101863924B (zh) 99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法
RU2009119451A (ru) Контрастные вещества для детекции рака предстательной железы
US10357576B2 (en) 18F-labelled folate/antifolate analogues
WO2011045415A2 (en) New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
ES2451642T3 (es) Derivados de indol tetracíclicos como agentes de formación de imágenes in vivo y que tienen afinidad por receptores de benzodiazepina periféricos (PBR)
KR20170012372A (ko) 뇌암을 치료하기 위한 화합물
RU2006107563A (ru) Зонды для заболеваний с накоплением амилоида, красители для амилоида, лекарства для лечения и профилактики заболеваний с накоплением амилоида, зонды для диагностики нейрофибриллярных клубков и красители для нейрофибриллярных клубков
JP6987840B2 (ja) Ido1酵素イメージングのための放射性リガンド
RU2006117819A (ru) Новые агенты визуализации, содержащие ингибиторы каспазы-3
JP2007500730A5 (enExample)
El-Kawy et al. Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
CN101646672B (zh) 用于诊断成像和放射治疗的叶酸轭合物和相应的金属螯合物络合物
JP2010523626A5 (enExample)
JP2009538894A5 (enExample)
CN103951668A (zh) 叶酸衍生物的正电子核素标记物及其应用
RU2007110372A (ru) Агенты визуализации, ингибирующие металлопротеиназу
JP6263716B2 (ja) 悪性腫瘍のpet診断用トレーサー
WO2014122228A1 (en) Labelled compounds that bind to alpha-v-beta-3 integrin
CN101486734A (zh) 99Tcm(CO)3环丙沙星氨荒酸盐配合物及制备方法和应用
WO2016178852A1 (en) 211-astatine containing radiotherapeutics for the treatment of cancer